Lee, Hak Joo
Feliers, Denis
Barnes, Jeffrey L.
Oh, Sae
Choudhury, Goutam Ghosh
Diaz, Vivian
Galvan, Veronica
Strong, Randy
Nelson, James
Salmon, Adam
Kevil, Christopher G.
Kasinath, Balakuntalam S.
Funding for this research was provided by:
National Institutes of Health (1P30-AG013319), DK50190, HL113303, AG050797)
U.S. Department of Veterans Affairs (I01BX001340, 5I01BX000926, IK6BX003611, I01BX002211, II01BX001641)
American Heart Association (15GRNT25700363)
Article History
Received: 23 March 2018
Accepted: 9 April 2018
First Online: 1 May 2018
Change Date: 28 January 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11357-021-00326-0
Compliance with ethical standards
: The Institutional Animal Care and Utilization Committee of the University of Texas Health at San Antonio approved the animal studies.
: CGK has intellectual property for hydrogen sulfide measurement and biomarker and also has equity interest in Innolyzer LLC and Theravasc Inc. J.L.B. is a consultant and co-founder of Probetex, Inc. with ownership interests. All other authors declare that they have no conflict of interest.